Neurocrine Biosciences Inc
2013 Q4 - 2025 Q4 (28 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/27/2026 | 13,821 | 0.0% | 97,450 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 9,457 | 0.0% | 67,369 | 9/30/2025 |
| 2025 Q2 | 8/7/2025 | 8,576 | 0.0% | 68,234 | 6/30/2025 |
| 2025 Q1 | 5/7/2025 | 12,693 | 0.0% | 114,765 | 3/31/2025 |
| 2024 Q4 | 2/7/2025 | 8,362 | 0.0% | 61,260 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 7,017 | 0.0% | 60,900 | 9/30/2024 |
| 2024 Q2 | 7/29/2024 | 12,393 | 0.0% | 90,018 | 6/30/2024 |
| 2024 Q1 | 4/25/2024 | 8,802 | 0.0% | 63,823 | 3/31/2024 |
| 2023 Q4 | 1/30/2024 | 5,921 | 0.0% | 44,939 | 12/31/2023 |
| 2023 Q3 | 10/25/2023 | 2,216 | 0.0% | 19,694 | 9/30/2023 |
| 2023 Q2 | 8/7/2023 | 1,895 | 0.0% | 20,094 | 6/30/2023 |
| 2023 Q1 | 5/8/2023 | 2,033 | 0.0% | 20,089 | 3/31/2023 |
| 2022 Q4 | 2/1/2023 | 2,379 | 0.0% | 19,921 | 12/31/2022 |
| 2022 Q3 | 11/9/2022 | 2,199 | 0.0% | 20,706 | 9/30/2022 |
| 2022 Q2 | 8/9/2022 | 1,934 | 0.0% | 19,837 | 6/30/2022 |
| 2022 Q1 | 4/21/2022 | 1,695 | 0.0% | 18,085 | 3/31/2022 |
| 2021 Q4 | 2/1/2022 | 1,548 | 0.0% | 18,176 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 1,931 | 0.0% | 20,133 | 9/30/2021 |
| 2021 Q2 | 7/30/2021 | 1,967 | 0.0% | 20,216 | 6/30/2021 |
| 2021 Q1 | 5/3/2021 | 1,949 | 0.0% | 20,036 | 3/31/2021 |
| 2020 Q4 | 1/28/2021 | 1,436 | 0.0% | 14,979 | 12/31/2020 |
| 2020 Q3 | 11/6/2020 | 2,617 | 0.0% | 27,219 | 9/30/2020 |
| 2020 Q2 | 7/28/2020 | 2,709 | 0.0% | 22,207 | 6/30/2020 |
| 2020 Q1 | 5/6/2020 | 1,642 | 0.0% | 18,969 | 3/31/2020 |
| 2019 Q4 | 1/21/2020 | 1,924 | 0.0% | 17,896 | 12/31/2019 |
| 2014 Q2 | 8/6/2014 | 668 | 0.0% | 45,000 | 6/30/2014 |
| 2014 Q1 | 4/29/2014 | 725 | 0.0% | 45,000 | 3/31/2014 |
| 2013 Q4 | 2/3/2014 | 420 | 0.0% | 45,000 | 12/31/2013 |